SPDR S&P Biotech ETF (XBI) option IV low into ASCO 2023
Tweet
Share
E-mailSPDR S&P Biotech ETF (NYSE: XBI) 30-day option implied volatility at 28; compared to its 52-week range of 28 to 57 into ACSCO 2023.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intuitive Machines (LUNR) August 14 weekly calls active into quarter results
- Global S&P Futures mixed in premarket
- Market Vectors Gold Miners ETF (GDX) call put ratio 2 calls to 1 put on as gold trades $4437
Create E-mail Alert Related Categories
OptionsRelated Entities
Standard & Poor's, OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
